We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

97 hedge funds and large institutions have $127M invested in Surgalign Holdings, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8% less funds holding

Funds holding: 10697 (-9)

11% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 36

32% less capital invested

Capital invested by funds: $185M → $127M (-$58.4M)

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

Holders
97
Holders Change
-9
Holders Change %
-8.49%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
6
Increased
32
Reduced
36
Closed
15
Calls
Puts
Net Calls
Net Calls Change

SRGA Hedge Fund Activity: Q3 2019 in Review

97 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2019, worth a combined $127M — down 32% from $185M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SRGA and 6 opened new positions — a net loss of 9 holders — while 36 trimmed existing stakes and 32 added.

The largest buyer was HealthCor Management, opening a new position worth an estimated $7.68M. The largest seller was Wedge Capital Management, exiting entirely with an estimated $1.36M sold.

  • 97 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2019, down from 106 in Q2 2019.
  • Funds reported $127M of Surgalign Holdings, Inc. Common Stock stock for Q3 2019, down 32% quarter-over-quarter.
  • 6 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2019 and 15 closed out, a net change of -9 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2019 was HealthCor Management, an estimated $7.68M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2019 was Wedge Capital Management, an estimated $1.36M sold.

Based on aggregated 13F filings for Q3 2019.